Bristol-Myers Squibb Company
숏
업데이트됨

[BMY] SELL SETUP

1 434
Simple Sell Setup with a interesting Risk Ratio ( > 1:3 ). Details below or on chart:

FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.


SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------

- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================

MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------

- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$


TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)


...Thank you for your support and trade with care!
노트
...pending order
노트
스냅샷
노트
Rebound in play... follow our idea!
거래청산: 타겟 닿음
스냅샷

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.